Arcutis Biotherapeutics, Inc. ARQT Gross margin
Gross margin at other companies
Other financials
Where this comes from
Calculated from Arcutis Biotherapeutics, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Arcutis Biotherapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arcutis Biotherapeutics, Inc.'s gross margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arcutis Biotherapeutics, Inc.'s gross margin?
- Arcutis Biotherapeutics, Inc. (ARQT) reported gross margin of 90.9% in Q1 2026.
- How has Arcutis Biotherapeutics, Inc.'s gross margin changed year-over-year?
- Arcutis Biotherapeutics, Inc.'s gross margin increased by 2.9% year-over-year, from 88.4% to 90.9%.
- What is the long-term trend for Arcutis Biotherapeutics, Inc.'s gross margin?
- Over 3 years (2022 to 2025), Arcutis Biotherapeutics, Inc.'s gross margin has grown at a 4.3% compound annual growth rate (CAGR), from 79.5% to 90.2%.
- What does gross margin mean?
- Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.